Abstract
The drug discovery market based on RNAi is projected to be $650 million in 2005 and $1 billion by
2010. Dont miss out on your share of this growing market! The increasing demand for target
validation and the large number of new potential targets has augmented the need and importance of
RNAi in sorting through the possibilities. The future is bright for this technology in that it may
supplant or complement crucial existing technologies such as antisense and knockout models. As the
first drugs are commercialized there will be an even greater interest in this exciting new
technology.
View Cart
